Lung Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020

Lung Cancer Diagnostic Tests include assays of mostly antibodies released in response to a lung cancer and cancer-causing proteins. GlobalData’s Medical Devices sector report, “Lung Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020″ provides comprehensive information about the Lung Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Lung Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Lung Cancer Diagnostic Tests under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Lung Cancer Diagnostic Tests pipeline products.

Review of Recent Developments in the segment / industry

The Lung Cancer Diagnostic Tests Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Lung Cancer Diagnostic Tests- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

Extensive coverage of the Lung Cancer Diagnostic Tests under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Lung Cancer Diagnostic Tests and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to:

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Lung Cancer Diagnostic Tests under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

A&G Pharmaceutical Inc

Abbott Diagnostics

Abcodia Ltd

Aberystwyth University

Abnova Corp

Acobiom

Advanced Marker Discovery SL

AIT Austrian Institute of Technology GmbH

Almac Diagnostic Services Ltd

Anixa Diagnostics Corporation

Armune BioScience Inc

Aurelium BioPharma Inc.

Avant Diagnostics Inc

BARD1 Life Sciences Ltd

BioAffinity Technologies, Inc.

Biocept Inc

Biodesix Inc

Biological Dynamics Inc

BioMark Diagnostics Inc

BioMarker Strategies LLC

BioNTech SE

BioSystems International

Boston Children’s Hospital

Cancer Genetics Inc

Cancer Research Technology Ltd

Cangen Biotechnologies Inc (Inactive)

CDI Laboratories Inc

Celcuity Inc

Cellanyx Diagnostics, Inc.

Cellmid Ltd

CeMines, Inc. (Inactive)

Cepheid Inc

Ceres Nanosciences Inc

Cernostics Inc

ChemImage Corp

Clarient Inc

Courtagen Life Sciences Inc

Creatv MicroTech Inc

DiagnoCure Inc. (Inactive)

EDP Biotech Corporation

Emory University

Enterome Bioscience SA

Entopsis LLC

Epic Sciences Inc

Epigenomics AG

Eventus Diagnostics Inc (Inactive)

Exact Sciences Corp

Exiqon AS

Exosome Diagnostics Inc

Exosomics Siena SpA

Fahy Gurteen UK Ltd

FibroStatin SL

Fina Biotech SL

French National Institute of Health and Medical Research

Gene Express, Inc. (Inactive)

GeneCentric Diagnostics, Inc.

Genome Profiling LLC

Global Discovery Biosciences Corporation

GlycoZym USA Inc

Guardant Health Inc

ImmunePharma Srl

ImmunoCellular Therapeutics Ltd

Immunovia AB

Insight Genetics Inc

InterGenetics Inc

Louisville Bioscience Inc (Inactive)

Massachusetts General Hospital

Mayo Clinic

MDNA Life Sciences Inc

MDxHealth SA

MEDITE Cancer Diagnostics Inc

Memory Dx LLC

Merrimack Pharmaceuticals Inc

Metabolon Inc

Metanomics Health GmbH

MetaStat Inc

Milagen Inc

Myriad International GmbH

Nagoya University

Nanocytomics LLC

Nanostics Inc

NEOMICS Co Ltd

NovaGray

Novel Bio-spectrum Technologies Inc (Inactive)

Oncimmune (USA) LLC

OncoCyte Corp

Oncolome Diagnostics Inc (Inactive)

Onconome, Inc. (Inactive)

OncoStem Diagnostics Pvt. Ltd

OPKO Health Inc

Orion Genomics LLC

OTraces Inc

Peri Rx Inc

PleX Diagnostics Inc (Inactive)

PreMD Inc (Inactive)

Proplex Technologies Llc

Proteome Sciences Plc

Proteomika (Inactive)

Quanterix Corp

Queensland University of Technology

Research Center Borstel

Roche Diagnostics International Ltd

Rosetta Genomics Ltd

Roswell Park Cancer Institute

Savicell Diagnostic Ltd.

Sengenics Corp Pte Ltd

Shenzhen Mindray Bio-Medical Electronics Co Ltd

Siemens Healthcare Diagnostics Inc

Sienna Cancer Diagnostics Ltd

Simon Fraser University

SomaLogic Inc

Southern Illinois University Carbondale

Sysmex Corp

Taizhou ZECEN Biotech Co Ltd

The Prince Charles Hospital

Thermo Fisher Scientific Inc

Transgene SA

Treos Bio Inc

Universal Diagnostics SL

University of California San Francisco

University of Chicago

University of Colorado

University of Maryland

University of Queensland

University of South Florida

University of Texas MD Anderson Cancer Center

US Biomarkers Inc

Vanderbilt University

Ventana Medical Systems Inc

Viomics Inc.

VisionGate Inc

VolitionRX Ltd

XEPTAGEN SpA

Zetiq Technologies Ltd

ZORA Biosciences Oy

Table of Contents

1 Table of Contents 2

1.1 List of Tables 10

1.2 List of Figures 19

2 Introduction 20

2.1 Lung Cancer Overview 20

3 Products under Development 21

3.1 Lung Cancer – Pipeline Products by Stage of Development 21

3.2 Lung Cancer – Pipeline Products by Territory 22

3.3 Lung Cancer – Pipeline Products by Regulatory Path 23

3.4 Lung Cancer – Pipeline Products by Estimated Approval Date 24

3.5 Lung Cancer – Ongoing Clinical Trials 25

4 Lung Cancer – Pipeline Products under Development by Companies 26

4.1 Lung Cancer Companies – Pipeline Products by Stage of Development 26

4.2 Lung Cancer – Pipeline Products by Stage of Development 31

5 Lung Cancer Companies and Product Overview 36

5.1 A&G Pharmaceutical Inc Company Overview 36

5.1.1 A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.2 Abbott Diagnostics Company Overview 38

5.2.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 38

5.3 Abcodia Ltd Company Overview 44

5.3.1 Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

5.4 Aberystwyth University Company Overview 46

5.4.1 Aberystwyth University Pipeline Products & Ongoing Clinical Trials Overview 46

5.5 Abnova Corp Company Overview 47

5.5.1 Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview 47

5.6 Acobiom Company Overview 48

5.6.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 48

5.7 Advanced Marker Discovery SL Company Overview 50

5.7.1 Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview 50

5.8 AIT Austrian Institute of Technology GmbH Company Overview 53

5.8.1 AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 53

5.9 Almac Diagnostic Services Ltd Company Overview 54

5.9.1 Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.10 Anixa Diagnostics Corporation Company Overview 56

5.10.1 Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 56

5.11 Armune BioScience Inc Company Overview 61

5.11.1 Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.12 Aurelium BioPharma Inc. Company Overview 62

5.12.1 Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 62

5.13 Avant Diagnostics Inc Company Overview 63

5.13.1 Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.14 BARD1 Life Sciences Ltd Company Overview 64

5.14.1 BARD1 Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.15 BioAffinity Technologies, Inc. Company Overview 65

5.15.1 BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65

5.16 Biocept Inc Company Overview 68

5.16.1 Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.17 Biodesix Inc Company Overview 70

5.17.1 Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.18 Biological Dynamics Inc Company Overview 72

5.18.1 Biological Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.19 BioMark Diagnostics Inc Company Overview 73

5.19.1 BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.20 BioMarker Strategies LLC Company Overview 74

5.20.1 BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 74

5.21 BioNTech SE Company Overview 76

5.21.1 BioNTech SE Pipeline Products & Ongoing Clinical Trials Overview 76

5.22 BioSystems International Company Overview 77

5.22.1 BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 77

5.23 Boston Children’s Hospital Company Overview 78

5.23.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 78

5.24 Cancer Genetics Inc Company Overview 79

5.24.1 Cancer Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.25 Cancer Research Technology Ltd Company Overview 80

5.25.1 Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

5.26 Cangen Biotechnologies Inc (Inactive) Company Overview 81

5.26.1 Cangen Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 81

5.27 CDI Laboratories Inc Company Overview 82

5.27.1 CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.28 Celcuity Inc Company Overview 83

5.28.1 Celcuity Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.29 Cellanyx Diagnostics, Inc. Company Overview 84

5.29.1 Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 84

5.30 Cellmid Ltd Company Overview 85

5.30.1 Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview 85

5.31 CeMines, Inc. (Inactive) Company Overview 86

5.31.1 CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 86

5.32 Cepheid Inc Company Overview 87

5.32.1 Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 87

5.33 Ceres Nanosciences Inc Company Overview 89

5.33.1 Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.34 Cernostics Inc Company Overview 90

5.34.1 Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.35 ChemImage Corp Company Overview 91

5.35.1 ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview 91

5.36 Clarient Inc Company Overview 92

5.36.1 Clarient Inc Pipeline Products & Ongoing Clinical Trials Overview 92

5.37 Courtagen Life Sciences Inc Company Overview 94

5.37.1 Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 94

5.38 Creatv MicroTech Inc Company Overview 95

5.38.1 Creatv MicroTech Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.39 DiagnoCure Inc. (Inactive) Company Overview 96

5.39.1 DiagnoCure Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 96

5.40 EDP Biotech Corporation Company Overview 97

5.40.1 EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview 97

5.41 Emory University Company Overview 98

5.41.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 98

5.42 Enterome Bioscience SA Company Overview 99

5.42.1 Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 99

5.43 Entopsis LLC Company Overview 100

5.43.1 Entopsis LLC Pipeline Products & Ongoing Clinical Trials Overview 100

5.44 Epic Sciences Inc Company Overview 101

5.44.1 Epic Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.45 Epigenomics AG Company Overview 102

5.45.1 Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview 102

5.46 Eventus Diagnostics Inc (Inactive) Company Overview 103

5.46.1 Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 103

5.47 Exact Sciences Corp Company Overview 104

5.47.1 Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 104

5.48 Exiqon AS Company Overview 105

5.48.1 Exiqon AS Pipeline Products & Ongoing Clinical Trials Overview 105

5.49 Exosome Diagnostics Inc Company Overview 106

5.49.1 Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 106

5.50 Exosomics Siena SpA Company Overview 107

5.50.1 Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 107

5.51 Fahy Gurteen UK Ltd Company Overview 108

5.51.1 Fahy Gurteen UK Ltd Pipeline Products & Ongoing Clinical Trials Overview 108

5.52 FibroStatin SL Company Overview 109

5.52.1 FibroStatin SL Pipeline Products & Ongoing Clinical Trials Overview 109

5.53 Fina Biotech SL Company Overview 110

5.53.1 Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 110

5.54 French National Institute of Health and Medical Research Company Overview 111

5.54.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 111

5.55 Gene Express, Inc. (Inactive) Company Overview 112

5.55.1 Gene Express, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 112

5.56 GeneCentric Diagnostics, Inc. Company Overview 114

5.56.1 GeneCentric Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114

5.57 Genome Profiling LLC Company Overview 115

5.57.1 Genome Profiling LLC Pipeline Products & Ongoing Clinical Trials Overview 115

5.58 Global Discovery Biosciences Corporation Company Overview 116

5.58.1 Global Discovery Biosciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 116

5.59 GlycoZym USA Inc Company Overview 117

5.59.1 GlycoZym USA Inc Pipeline Products & Ongoing Clinical Trials Overview 117

5.60 Guardant Health Inc Company Overview 118

5.60.1 Guardant Health Inc Pipeline Products & Ongoing Clinical Trials Overview 118

5.61 ImmunePharma Srl Company Overview 121

5.61.1 ImmunePharma Srl Pipeline Products & Ongoing Clinical Trials Overview 121

5.62 ImmunoCellular Therapeutics Ltd Company Overview 122

5.62.1 ImmunoCellular Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

5.63 Immunovia AB Company Overview 123

5.63.1 Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview 123

5.64 Insight Genetics Inc Company Overview 126

5.64.1 Insight Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.65 InterGenetics Inc Company Overview 128

5.65.1 InterGenetics Inc Pipeline Products & Ongoing Clinical Trials Overview 128

5.66 Louisville Bioscience Inc (Inactive) Company Overview 129

5.66.1 Louisville Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 129

5.67 Massachusetts General Hospital Company Overview 130

5.67.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 130

5.68 Mayo Clinic Company Overview 131

5.68.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 131

5.69 MDNA Life Sciences Inc Company Overview 132

5.69.1 MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 132

5.70 MDxHealth SA Company Overview 133

5.70.1 MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 133

5.71 MEDITE Cancer Diagnostics Inc Company Overview 134

5.71.1 MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 134

5.72 Memory Dx LLC Company Overview 135

5.72.1 Memory Dx LLC Pipeline Products & Ongoing Clinical Trials Overview 135

5.73 Merrimack Pharmaceuticals Inc Company Overview 136

5.73.1 Merrimack Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 136

5.74 Metabolon Inc Company Overview 137

5.74.1 Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 137

5.75 Metanomics Health GmbH Company Overview 138

5.75.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 138

5.76 MetaStat Inc Company Overview 139

5.76.1 MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview 139

5.77 Milagen Inc Company Overview 140

5.77.1 Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview 140

5.78 Myriad International GmbH Company Overview 141

5.78.1 Myriad International GmbH Pipeline Products & Ongoing Clinical Trials Overview 141

5.79 Nagoya University Company Overview 142

5.79.1 Nagoya University Pipeline Products & Ongoing Clinical Trials Overview 142

5.80 Nanocytomics LLC Company Overview 143

5.80.1 Nanocytomics LLC Pipeline Products & Ongoing Clinical Trials Overview 143

5.81 Nanostics Inc Company Overview 144

5.81.1 Nanostics Inc Pipeline Products & Ongoing Clinical Trials Overview 144

5.82 NEOMICS Co Ltd Company Overview 145

5.82.1 NEOMICS Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 145

5.83 NovaGray Company Overview 146

5.83.1 NovaGray Pipeline Products & Ongoing Clinical Trials Overview 146

5.84 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview 147

5.84.1 Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 147

5.85 Oncimmune (USA) LLC Company Overview 148

5.85.1 Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview 148

5.86 OncoCyte Corp Company Overview 151

5.86.1 OncoCyte Corp Pipeline Products & Ongoing Clinical Trials Overview 151

5.87 Oncolome Diagnostics Inc (Inactive) Company Overview 154

5.87.1 Oncolome Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 154

5.88 Onconome, Inc. (Inactive) Company Overview 155

5.88.1 Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 155

5.89 OncoStem Diagnostics Pvt. Ltd Company Overview 156

5.89.1 OncoStem Diagnostics Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 156

5.90 OPKO Health Inc Company Overview 157

5.90.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 157

5.91 Orion Genomics LLC Company Overview 158

5.91.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 158

5.92 OTraces Inc Company Overview 159

5.92.1 OTraces Inc Pipeline Products & Ongoing Clinical Trials Overview 159

5.93 Peri Rx Inc Company Overview 160

5.93.1 Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview 160

5.94 PleX Diagnostics Inc (Inactive) Company Overview 163

5.94.1 PleX Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 163

5.95 PreMD Inc (Inactive) Company Overview 164

5.95.1 PreMD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 164

5.96 Proplex Technologies Llc Company Overview 165

5.96.1 Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 165

5.97 Proteome Sciences Plc Company Overview 166

5.97.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 166

5.98 Proteomika (Inactive) Company Overview 167

5.98.1 Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 167

5.99 Quanterix Corp Company Overview 168

5.99.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 168

5.100 Queensland University of Technology Company Overview 170

5.100.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 170

5.101 Research Center Borstel Company Overview 171

5.101.1 Research Center Borstel Pipeline Products & Ongoing Clinical Trials Overview 171

5.102 Roche Diagnostics International Ltd Company Overview 172

5.102.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 172

5.103 Rosetta Genomics Ltd Company Overview 175

5.103.1 Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview 175

5.104 Roswell Park Cancer Institute Company Overview 176

5.104.1 Roswell Park Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview 176

5.105 Savicell Diagnostic Ltd. Company Overview 177

5.105.1 Savicell Diagnostic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 177

5.106 Sengenics Corp Pte Ltd Company Overview 178

5.106.1 Sengenics Corp Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 178

5.107 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 179

5.107.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 179

5.108 Siemens Healthcare Diagnostics Inc Company Overview 181

5.108.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 181

5.109 Sienna Cancer Diagnostics Ltd Company Overview 184

5.109.1 Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 184

5.110 Simon Fraser University Company Overview 185

5.110.1 Simon Fraser University Pipeline Products & Ongoing Clinical Trials Overview 185

5.111 SomaLogic Inc Company Overview 186

5.111.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 186

5.112 Southern Illinois University Carbondale Company Overview 187

5.112.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 187

5.113 Sysmex Corp Company Overview 188

5.113.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 188

5.114 Taizhou ZECEN Biotech Co Ltd Company Overview 189

5.114.1 Taizhou ZECEN Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 189

5.115 The Prince Charles Hospital Company Overview 190

5.115.1 The Prince Charles Hospital Pipeline Products & Ongoing Clinical Trials Overview 190

5.116 Thermo Fisher Scientific Inc Company Overview 191

5.116.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 191

5.117 Transgene SA Company Overview 192

5.117.1 Transgene SA Pipeline Products & Ongoing Clinical Trials Overview 192

5.118 Treos Bio Inc Company Overview 193

5.118.1 Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 193

5.119 Universal Diagnostics SL Company Overview 194

5.119.1 Universal Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview 194

5.120 University of California San Francisco Company Overview 195

5.120.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 195

5.121 University of Chicago Company Overview 196

5.121.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 196

5.122 University of Colorado Company Overview 197

5.122.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 197

5.123 University of Maryland Company Overview 198

5.123.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 198

5.124 University of Queensland Company Overview 199

5.124.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 199

5.125 University of South Florida Company Overview 200

5.125.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 200

5.126 University of Texas MD Anderson Cancer Center Company Overview 201

5.126.1 University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 201

5.127 US Biomarkers Inc Company Overview 202

5.127.1 US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 202

5.128 Vanderbilt University Company Overview 203

5.128.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 203

5.129 Ventana Medical Systems Inc Company Overview 204

5.129.1 Ventana Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 204

5.130 Viomics Inc. Company Overview 207

5.130.1 Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview 207

5.131 VisionGate Inc Company Overview 208

5.131.1 VisionGate Inc Pipeline Products & Ongoing Clinical Trials Overview 208

5.132 VolitionRX Ltd Company Overview 209

5.132.1 VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview 209

5.133 XEPTAGEN SpA Company Overview 212

5.133.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 212

5.134 Zetiq Technologies Ltd Company Overview 213

5.134.1 Zetiq Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 213

5.135 ZORA Biosciences Oy Company Overview 214

5.135.1 ZORA Biosciences Oy Pipeline Products & Ongoing Clinical Trials Overview 214

6 Lung Cancer- Recent Developments 215

6.1 Oct 16, 2020: Moffitt researchers develop tool to better predict treatment course for lung cancer 215

6.2 Sep 21, 2020: Takeda and Foundation Medicine to collaborate on cancer diagnostics 215

6.3 Sep 16, 2020: Insmed to host R&D day on September 30, 2020 216

6.4 Sep 15, 2020: Transition to electric vehicles would set america on path to save thousands of lives, avoid billions in healthcare costs 216

6.5 Sep 01, 2020: Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality 217

6.6 Jul 28, 2020: Thynk Health helps CHI Memorial Chattanooga grow mobile lung screening program 219

6.7 Jul 22, 2020: Cancer Research Institute and the Mark Foundation for Cancer Research launch research collaboration to evaluate liquid biopsy for lung Cancer patient response to immunotherapy 220

6.8 Jul 16, 2020: Improving lung cancer CT screening performance in real-world settings 221

6.9 Jul 15, 2020: New promising treatment uses smart nanoparticles to target lung cancer 222

6.10 Jul 06, 2020: Supporting the discovery of novel blood biomarkers for lung cancer diagnostics 223

6.11 Jun 26, 2020: Sienna Cancer Diagnostics: Change of registered office 225

6.12 Jun 25, 2020: SEC charges Novartis with FCPA violations 225

6.13 Jun 24, 2020: Neural network can determine lung cancer severity 226

6.14 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities 226

6.15 Jun 02, 2020: Pfizer establishes new program to support continued biotechnology innovation 227

6.16 May 28, 2020: QIAGEN builds on leading position in Precision Medicine with novel solutions in oncology 227

6.17 May 18, 2020: QIAGEN announces publication of Reasoned Position Statement for proposed acquisition by Thermo Fisher and date for Annual General Meeting 228

6.18 May 13, 2020: OPKO Health’s BioReference Laboratories and Westchester Medical Center Health Network enter into strategic laboratory collaboration to deliver operational and diagnostic services 229

6.19 Apr 29, 2020: Cancer testing and diagnosis suffers sharp downturn, finds Diaceutics 229

6.20 Apr 15, 2020: Indivumed launches global oncology alliance for personalized medicine (“Onco AI-Med”) 230

6.21 Apr 15, 2020: Precision Biologics took $150,000-350,000 PPP government loan for COVID-19-struck small businesses, FOIA request shows 231

6.22 Apr 08, 2020: Immunovia and Global Pharmaceutical Company agree on early termination of lung cancer Collaboration 232

6.23 Apr 03, 2020: StageZero Life Sciences announces publication of abstract at american society of clinical oncology 232

6.24 Mar 20, 2020: Artificial Intelligence may help predict responses to systemic therapies in patients with Non-small Cell Lung Cancer 233

6.25 Mar 12, 2020: Lineage Cell Therapeutics reports fourth quarter and full year 2019 financial results and provides business update 234

6.26 Mar 04, 2020: Oncimmune Holdings: US commercial launch 238

6.27 Mar 03, 2020: Baron & Budd moves forward with false claims act case against AstraZeneca 239

6.28 Feb 29, 2020: MGI’s response to Illumina’s complaint 239

6.29 Feb 27, 2020: James Quincey elected to Pfizer’s board of directors 240

6.30 Feb 27, 2020: Inivata’s Nitzan Rosenfeld to receive 2020 Cancer Researcher Award from the European Association for Cancer Research and Pezcoller Foundation 240

6.31 Feb 26, 2020: MDxHealth reports financial year 2019 results and provides outlook for 2020 241

6.32 Feb 26, 2020: Mayo Clinic reports ‘remarkable growth’ in 2019 243

6.33 Feb 24, 2020: Oncology Venture & Alpha Blue Ocean mutually terminates agreement with EHGO as part of final financing 243

6.34 Feb 14, 2020: Pfizer: Appointment of Mr. Samir Kazi as an executive director 244

6.35 Feb 14, 2020: Pfizer: Resignation of Mr. Vivek Dhariwal 244

6.36 Feb 13, 2020: LabCorp announces 2019 fourth quarter and full year results and provides 2020 guidance 244

6.37 Feb 11, 2020: Exact Sciences announces fourth-quarter 2019 results 247

6.38 Feb 10, 2020: New imaging technology shows potential for multiple uses, particularly in medicine 248

6.39 Feb 06, 2020: Agilent Technologies announces Twist Bioscience agrees to pay $22.5 Million settlement in IP litigation 249

6.40 Feb 06, 2020: Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors 250

6.41 Feb 06, 2020: Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors 250

6.42 Feb 05, 2020: Merck announces fourth-quarter and full-year 2019 financial results 251

6.43 Feb 05, 2020: Merck to focus on key growth pillars through spinoff of women’s health, trusted legacy brands and biosimilars products into new company (“newco”) 255

6.44 Feb 05, 2020: GSK delivers 2019 sales of £33.8 billion +10% AER, +8% CER (Pro-forma +4% CER) 258

6.45 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed 259

6.46 Jan 31, 2020: Benitec Biopharma announces appendix 4C: quarterly cash flow report 261

6.47 Jan 31, 2020: Dr. Christine Seidman and Kathy Warden elected to Merck Board of Directors 262

6.48 Jan 30, 2020: Quest Diagnostics reports record fourth quarter and full year 2019 revenues and earnings; provides guidance for full year 2020; increases dividend

5.7% to $0.56 per quarter 262

6.49 Jan 30, 2020: OGT launches breakthrough NGS panel for constitutional cytogenetics 263

6.50 Jan 29, 2020: Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019 264

6.51 Jan 28, 2020: Oncimmune Holdings: EarlyCDT Lung Test more cost effective compared to CT surveillance 270

6.52 Jan 28, 2020: Pfizer reports fourth-quarter and full-year 2019 results 271

6.53 Jan 23, 2020: Agilent announces CrossLab Group leadership transition 278

6.54 Jan 22, 2020: Novartis establishes its new legal entity in Vietnam 279

6.55 Jan 22, 2020: GlaxoSmithKline signs agreement to invest £5M in Egypt 279

6.56 Jan 21, 2020: Biomark’s scientific advisor named Dean of the Schulich School of Medicine and Dentistry 279

6.57 Jan 13, 2020: Oncocyte announces the commercial availability of DetermaRx, the first test for chemotherapy benefit prediction in patients with early stage non-small cell lung cancer 280

6.58 Jan 13, 2020: HTG Molecular Diagnostics announces preliminary 2019 unaudited financial results 281

6.59 Jan 13, 2020: Enzo Biochem responds to series of misleading and inaccurate statements from activist hedge fund harbert 281

6.60 Jan 12, 2020: Exact Sciences announces preliminary fourth quarter 2019 results 285

6.61 Jan 08, 2020: Deborah Waterhouse, CEO of ViiV Healthcare, to join GSK Corporate Executive Team (CET) 286

6.62 Jan 07, 2020: BioMarker Strategies awarded phase II National Cancer Institute contract to develop novel predictive test for response to immunotherapies for patients with non-small cell lung cancer 287

6.63 Jan 07, 2020: OncoCyte announces successful completion of CLIA validation study of DetermaDx 287

6.64 Jan 06, 2020: Sienna makes Board appointment 288

6.65 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control 288

6.66 Jan 02, 2020: Pfizer, Sanofi and GlaxoSmithKline plan to increase US drug prices in 2020 289

6.67 Jan 02, 2020: Lineage Cell Therapeutics conducts sale of shares in oncocyte 289

6.68 Dec 31, 2019: Enzo Biochem appoints Rebecca J. Fischer to Board of Directors 290

6.69 Dec 31, 2019: Biomark announces appointment of Scientific and Medical Advisors, grant of stock options and changes in Board Of Directors 291

6.70 Dec 29, 2019: Illumina reports financial results for fourth quarter and fiscal year 2019 291

6.71 Dec 24, 2019: Ad-hoc announcement pursuant to article 17 market abuse regulation 293

6.72 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 293

6.73 Dec 19, 2019: Biomark Diagnostics reviews 2019 and outlines plans for 2020 294

6.74 Dec 18, 2019: Pfizer and Mylan announce two future Viatris board members 297

6.75 Dec 17, 2019: Case Western Reserve researchers to lead Northeast Ohio initiative to prevent, detect and treat lung cancer in underserved communities 298

6.76 Dec 16, 2019: Pfizer declares first-quarter 2020 dividend and announces upcoming investor day to highlight strength of innovative R&D pipeline 299

6.77 Dec 10, 2019: Enzo Biochem reports fiscal first quarter results 299

6.78 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses 302

6.79 Dec 05, 2019: VolitionRx and Gyros Protein Technologies awarded an aggregate $1 million+ Eurostars Cash grant to collaborate on developing a Lung Cancer Blood Test 302

6.80 Dec 05, 2019: Novartis expects to sustain long-term growth with a robust pipeline of 25+ potential blockbusters highlighted at R&D Day 303

6.81 Dec 05, 2019: Enzo Biochem issues open letter to shareholders 304

6.82 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 308

6.83 Nov 29, 2019: Immunovia continues with next stage of the Lung Cancer Project together with Global Pharma Partner 309

6.84 Nov 29, 2019: Oncology Venture publishes Interim Report for the period January – September 2019 309

6.85 Nov 28, 2019: One Nucleus announces finalists of the BioNewsRound Award 311

6.86 Nov 27, 2019: ASX/nasdaq announcement: Re-domiciliation to the united states 311

6.87 Nov 26, 2019: LabCorp appoints senior finance executive Jeffrey A. Davis to its Board of Directors 313

7 Appendix 314

7.1 Methodology 314

7.2 About GlobalData 318

7.3 Contact Us 318

List of Tables

Table 1: Lung Cancer – Pipeline Products by Stage of Development 21

Table 2: Lung Cancer – Pipeline Products by Territory 22

Table 3: Lung Cancer – Pipeline Products by Regulatory Path 23

Table 4: Lung Cancer – Pipeline Products by Estimated Approval Date 24

Table 5: Lung Cancer – Ongoing Clinical Trials 25

Table 6: Lung Cancer Companies – Pipeline Products by Stage of Development 26

Table 7: Lung Cancer – Pipeline Products by Stage of Development 31

Table 8: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Table 13: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 38

Table 30: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

Table 35: Aberystwyth University Pipeline Products & Ongoing Clinical Trials Overview 46

Table 41: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 48

Table 46: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview 50

Table 53: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 53

Table 56: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

Table 61: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 56

Table 72: Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Table 75: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 62

Table 78: Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Table 81: BARD1 Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

Table 84: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65

Table 89: Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Table 94: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Table 99: Biological Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 72

Table 102: BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 73

Table 105: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 74

Table 110: BioNTech SE Pipeline Products & Ongoing Clinical Trials Overview 76

Table 113: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 77

Table 116: Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 78

Table 119: Cancer Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 79

Table 122: Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

Table 125: Cangen Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 81

Table 128: CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 82

Table 131: Celcuity Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Table 134: Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 84

Table 137: Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview 85

Table 140: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 86

Table 143: Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 87

Table 148: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 89

Table 151: Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview 90

Table 154: ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview 91

Table 157: Clarient Inc Pipeline Products & Ongoing Clinical Trials Overview 92

Table 162: Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 94

Table 165: Creatv MicroTech Inc Pipeline Products & Ongoing Clinical Trials Overview 95

Table 168: DiagnoCure Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 96

Table 171: EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview 97

Table 174: Emory University Pipeline Products & Ongoing Clinical Trials Overview 98

Table 177: Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 99

Table 180: Entopsis LLC Pipeline Products & Ongoing Clinical Trials Overview 100

Table 183: Epic Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 101

Table 186: Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview 102

Table 189: Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 103

Table 192: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 104

Table 195: Exiqon AS Pipeline Products & Ongoing Clinical Trials Overview 105

Table 198: Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 106

Table 201: Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 107

Table 204: Fahy Gurteen UK Ltd Pipeline Products & Ongoing Clinical Trials Overview 108

Table 207: FibroStatin SL Pipeline Products & Ongoing Clinical Trials Overview 109

Table 210: Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 110

Table 213: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 111

Table 216: Gene Express, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 112

Table 221: GeneCentric Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114

Table 224: Genome Profiling LLC Pipeline Products & Ongoing Clinical Trials Overview 115

Table 227: Global Discovery Biosciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 116

Table 230: GlycoZym USA Inc Pipeline Products & Ongoing Clinical Trials Overview 117

Table 233: Guardant Health Inc Pipeline Products & Ongoing Clinical Trials Overview 118

Table 240: ImmunePharma Srl Pipeline Products & Ongoing Clinical Trials Overview 121

Table 243: ImmunoCellular Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

Table 246: Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview 123

Table 251: Insight Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 126

Table 256: InterGenetics Inc Pipeline Products & Ongoing Clinical Trials Overview 128

Table 259: Louisville Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 129

Table 262: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 130

Table 265: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 131

Table 268: MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 132

Table 271: MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 133

Table 274: MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 134

Table 277: Memory Dx LLC Pipeline Products & Ongoing Clinical Trials Overview 135

Table 280: Merrimack Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 136

Table 283: Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 137

Table 286: Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 138

Table 289: MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview 139

Table 292: Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview 140

Table 295: Myriad International GmbH Pipeline Products & Ongoing Clinical Trials Overview 141

Table 298: Nagoya University Pipeline Products & Ongoing Clinical Trials Overview 142

Table 301: Nanocytomics LLC Pipeline Products & Ongoing Clinical Trials Overview 143

Table 304: Nanostics Inc Pipeline Products & Ongoing Clinical Trials Overview 144

Table 307: NEOMICS Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 145

Table 310: NovaGray Pipeline Products & Ongoing Clinical Trials Overview 146

Table 313: Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 147

Table 316: Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview 148

Table 321: OncoCyte Corp Pipeline Products & Ongoing Clinical Trials Overview 151

Table 330: Oncolome Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 154

Table 333: Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 155

Table 336: OncoStem Diagnostics Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 156

Table 339: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 157

Table 342: Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 158

Table 345: OTraces Inc Pipeline Products & Ongoing Clinical Trials Overview 159

Table 348: Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview 160

Table 353: PleX Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 163

Table 356: PreMD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 164

Table 359: Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 165

Table 362: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 166

Table 365: Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 167

Table 368: Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 168

Table 371: Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 170

Table 374: Research Center Borstel Pipeline Products & Ongoing Clinical Trials Overview 171

Table 377: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 172

Table 384: Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview 175

Table 387: Roswell Park Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview 176

Table 390: Savicell Diagnostic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 177

Table 393: Sengenics Corp Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 178

Table 396: Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 179

Table 399: Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 181

Table 406: Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 184

Table 409: Simon Fraser University Pipeline Products & Ongoing Clinical Trials Overview 185

Table 412: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 186

Table 415: Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 187

Table 418: Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 188

Table 421: Taizhou ZECEN Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 189

Table 424: The Prince Charles Hospital Pipeline Products & Ongoing Clinical Trials Overview 190

Table 427: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 191

Table 430: Transgene SA Pipeline Products & Ongoing Clinical Trials Overview 192

Table 433: Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 193

Table 436: Universal Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview 194

Table 439: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 195

Table 442: University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 196

Table 445: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 197

Table 448: University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 198

Table 451: University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 199

Table 454: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 200

Table 457: University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 201

Table 460: US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 202

Table 463: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 203

Table 466: Ventana Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 204

Table 473: Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview 207

Table 476: VisionGate Inc Pipeline Products & Ongoing Clinical Trials Overview 208

Table 479: VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview 209

Table 485: XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 212

Table 488: Zetiq Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 213

Table 491: ZORA Biosciences Oy Pipeline Products & Ongoing Clinical Trials Overview 214

Table 494: Glossary 317

List of Figures

Figure 1: Lung Cancer – Pipeline Products by Stage of Development 21

Figure 2: Lung Cancer – Pipeline Products by Territory 22

Figure 3: Lung Cancer – Pipeline Products by Regulatory Path 23

Figure 4: Lung Cancer – Pipeline Products by Estimated Approval Date 24

Figure 5: Lung Cancer – Ongoing Clinical Trials 25

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports